Biopharma company Allergan has reported stellar fourth-quarter adjusted earnings. The company also revealed that the first of two key trials for its migraine treatment ubrogepant were successful. For the fourth quarter, Allergan reported EPS of $4.86 while analysts had been calling for $4.74. Revenue at $4.33 billion was also ahead of the $4.28 billion that … Continue reading “Allergan Smashes in its Earnings Report”
Tag: Allergan
Biotech & Pharma
FDA Approves The First Drug To Help Stop Nightly Bathroom Visits
The U.S. Food and Drug Administration has just approved the first drug intended on reducing…
March 6, 2017
Hot Stocks
Allergan (AGN) Will Have To Pay $15M For This Wrongdoing
A unit of Allergan will have to shell out $15 million as a penalty after…
January 17, 2017
Hot Stocks
Allergan Just Announced A Huge $2.9 Billion Acquisition
Drugmaker Allergan had some big news on Tuesday morning. The company announced that it woud…
December 20, 2016
Biotech & Pharma
Allergan (AGN) May Pay A Lot Of Money For This Company
Pharmaeutical titan, Allergan, is acquiring Tobira Therapuetics in a deal that's initially for $28.35 per…
September 20, 2016
Hot Stocks
Allergan (AGN) Will Buy This Company For $95M
Headquartered in Dublin, Ireland, global pharmaceutical company Allergan, has just agreed to acquire private eye…
August 12, 2016
Biogen (BIIB) Shares Explode After WallStreet Report
A report by the Wall Street Journal, indicating that Merck & Co. and Allergan Plc…
August 2, 2016
Biotech & Pharma
Carl Icahn Gives In To Botox By Buying Stake In Allergan (NYSE: ACT)
Just a decade after it initially hit the market, Botox is one of the most…
May 31, 2016